Optipharm.CO.LTD (153710) — Cash Flow Reinvestment Rate
Optipharm.CO.LTD (153710) has a Cash Flow Reinvestment Rate of 1.27x as of June 2026, reinvesting ₩1.15 Billion (capex ₩130.67 Million plus investments ₩1.02 Billion) from operating cash flow of ₩905.29 Million. See Optipharm.CO.LTD (153710) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Optipharm.CO.LTD Cash Flow Reinvestment Rate (2016–2019)
Historical reinvestment intensity for Optipharm.CO.LTD across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does Optipharm.CO.LTD generate cash.
Annual Cash Flow Reinvestment Rate for Optipharm.CO.LTD (2016–2019)
Year-by-year capital reinvestment analysis for Optipharm.CO.LTD. See Optipharm.CO.LTD (153710) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 13.02x | ₩5.83 Billion | ₩447.47 Million | ₩626.46 Million | ▲ +6121.0% |
| 2018 | 0.21x | ₩251.91 Million | ₩1.20 Billion | ₩202.91 Million | ▼ -92.4% |
| 2017 | 2.77x | ₩722.33 Million | ₩260.86 Million | ₩670.33 Million | ▲ +473.4% |
| 2016 | 0.48x | ₩415.95 Million | ₩861.36 Million | ₩391.95 Million | — |